Vésale Bioscience named most innovative start-up in life sciences in Europe at tenth edition of BioFIT
Vésale Bioscience announces that it has been awarded…
read moreNew solutions to fight antibiotic resistant infections
Stem from our advanced R&D on bacteriophages, our Mission is to develop robust modern solutions to fight antibiotic-resistant infections.
Antibiotic-resistant infections, also known as antimicrobial resistance (AMR), are a substantial public health issue. From 700 000/y deaths today, the AMR burden is expected to reach ten million/y deaths by 2050, more than cancer.
Our approach is to work on personalized, selective, and specific phage therapies against those multi-resistant bacterial infections.
They talk about us.
Don’t miss any important events or news about Vésale Bioscience.
Vésale Bioscience announces that it has been awarded…
read moreGérald de Patoul joins the Vésale Bioscience team…
read more